Having exceeded expectations last quarter by 16 cents per share, Amgen (NASDAQ:AMGN) is scheduled to report again on Thursday.
Continue Reading Below
Analysts currently expect Amgen to come in with earnings of $1.51 per share on revenues of $4.08 billion. Analysts gave estimates ranging from earnings per share to earnings per share. Over the past three months, the average estimate has moved up from $1.49.
In terms of price changes, the stock's best recent streak was when it gained $5.79 per share between July 6, 2012 and July 19, 2012.
Company Fundamental Trends
Analysts think investors should stand pat on Amgen with 12 of 23 analysts rating it hold. Analyst sentiment has been improving recently, as the average rating risen slightly over the past three months.
Last Quarter's Results
In the first quarter, profit rose 5.2% to $1.18 billion ($1.48 a share) from $1.13 billion ($1.20 a share) the year earlier, exceeding analyst expectations. Revenue rose 9.2% to $4.05 billion from $3.71 billion.
Reporting Period: 2Q
Date of Release: Thursday, July 26, 2012
Revenue Estimate: $4.08 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)